Junyelt

Copper gluconate, manganese gluconate, potassium iodide, sodium selenite, and zinc gluconate, the active ingredients in Junyelt, are a multielement nutritional supplement presented as an unspecified strength/intravenous solution for intravenous use. They address trace element deficiency and support immune function in patients requiring parenteral nutrition.

GNH USA supplies Junyelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, and oncology clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution, ensuring product integrity from manufacture to delivery.

Junyelt provides trace elements that are essential for enzymatic processes and is used in clinical situations where deficiency or increased demand occurs.

- Trace element deficiency: restores adequate levels of copper, manganese, iodine, selenium, and zinc. - Immune support in immunocompromised patients: contributes to normal immune cell function. - Parenteral nutrition in postoperative or critically ill patients: supplies essential micronutrients. - Iodine deficiency disorders: supports thyroid hormone synthesis.

Intravenous administration of Junyelt may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Metallic taste: transient sensation during infusion. - Nausea: mild gastrointestinal upset. - Injection site erythema: redness at the infusion site.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring emergency treatment. - Severe electrolyte imbalance: abnormal copper or zinc levels causing organ dysfunction. - Hepatic dysfunction: elevated liver enzymes indicating liver stress.

Before initiating therapy, clinicians should consider several safety measures. - Assess baseline trace element levels: measure serum copper, zinc, manganese, iodine, and selenium before therapy. - Monitor renal and hepatic function: regular labs to detect organ stress. - Avoid use in patients with known hypersensitivity to any component. - Adjust dose in patients with Wilson’s disease or manganese overload. - Limit concurrent high‑dose oral mineral supplements: may cause toxicity. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Junyelt can interact with other medicines or supplements; awareness of the interaction level helps guide monitoring.

Major Interactions (Avoid): - Concurrent high‑dose copper or zinc supplements: risk of toxicity. - Thyroid hormone therapy: excess iodine may alter hormone levels. - Penicillamine therapy: chelates copper, reducing efficacy.

Moderate Interactions (Monitor Closely): - Diuretics: may affect electrolyte balance. - Anticoagulants: trace elements can influence coagulation parameters. - Iron supplements: competition for absorption may affect levels.